Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2024-11-29 00:00:00 ET · period of report 2024-11-26 · accession 0001628280-24-049476 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-29 | 2024-11-26 | BLFS | Foster Karen A. | Chief Quality, Ops | S - Sale | $27.20 | -252 | 157.0K | -0.2% | -$6,854 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-26 | S | D | 252 | $27.20 | 156,973 | D | — | — |